Sponsor Pipeline

AOP Orphan Pharmaceuticals AG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-30 NCT07736846 TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06317805 Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy… Pulmonary Arterial Hypertension Recruiting
Phase 3
NCT06350032 Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children… Pulmonary Arterial Hypertension Recruiting
NCT06514807 A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential… Essential Thrombocythaemia Active, Not Recruiting
Not specified
NCT06445673 A Prospective Non-interventional Observational Study to Observe Long-term Treatment and… Pulmonary Arterial Hypertension Enrolling by Invitation
NCT07736846 TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends Pulmonary Arterial Hypertension (PAH) Not Yet Recruiting
Disease Areas
Hypertension (4)
Get alerts when AOP Orphan Pharmaceuticals AG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free